感染威廉亚洲博彩公司

订阅

MedSci主页 / 所有栏目 / 感染威廉亚洲博彩公司

2017 ESCMID/ECMM/ERS威廉亚洲博彩公司 ：曲霉菌病的诊断和管理

2018-03-12 欧洲临床微生物与感染性疾病学会 Clin Microbiol Infect. 2018 Mar 12.

:曲霉菌病

2017欧洲曲霉菌病的诊断和管理威廉亚洲博彩公司 是由欧洲临床微生物与感染性疾病学会(ESCMID)、欧洲医学真菌学联盟(ECMM)联合欧洲呼吸学会(ERS)联合制定。威廉亚洲博彩公司 建议内容涉及诊断程序，胸部影像学检查，支气管肺泡灌洗和活组织检查，其他位置影像学检查，显微镜下检查以及抗真菌药敏测试等。

中文标题：

2017 ESCMID/ECMM/ERS威廉亚洲博彩公司 ：曲霉菌病的诊断和管理

英文标题：

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

发布机构：

欧洲临床微生物与感染性疾病学会

发布日期：

2018-03-12

简要介绍：

2017欧洲曲霉菌病的诊断和管理威廉亚洲博彩公司 是由欧洲临床微生物与感染性疾病学会(ESCMID)、欧洲医学真菌学联盟(ECMM)联合欧洲呼吸学会(ERS)联合制定。威廉亚洲博彩公司 建议内容涉及诊断程序，胸部影像学检查，支气管肺泡灌洗和活组织检查，其他位置影像学检查，显微镜下检查以及抗真菌药敏测试等。

 

拓展威廉亚洲博彩公司 ：与霉菌相关威廉亚洲博彩公司 ：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2017 ESCMID/ECMM/ERS威廉亚洲博彩公司 ：曲霉菌病的诊断和管理)] GetToolGuiderByIdResponse(projectId=1, id=9f88b1c0015698a0, title=2017 ESCMID/ECMM/ERS威廉亚洲博彩公司 ：曲霉菌病的诊断和管理, enTitle=Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline., guiderFrom=Clin Microbiol Infect. 2018 Mar 12., authorId=null, author=, summary=2017欧洲曲霉菌病的诊断和管理威廉亚洲博彩公司 是由欧洲临床微生物与感染性疾病学会(ESCMID)、欧洲医学真菌学联盟(ECMM)联合欧洲呼吸学会(ERS)联合制定。威廉亚洲博彩公司 建议内容涉及诊断程序，胸部影像学检查，支气管肺泡灌洗和活组织检查，其他位置影像学检查，显微镜下检查以及抗真菌药敏测试等。 , cover=, journalId=null, articlesId=null, associationId=166, associationName=欧洲临床微生物与感染性疾病学会, associationIntro=欧洲临床微生物与感染性疾病学会（ESCMID）成立于1983年，在德国注册。现在世界各地的正式会员有4100余人。它在微生物学和传染病学领域具有一定的影响力。, copyright=0, guiderPublishedTime=Mon Mar 12 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>2017欧洲曲霉菌病的诊断和管理威廉亚洲博彩公司 是由欧洲临床微生物与感染性疾病学会(ESCMID)、欧洲医学真菌学联盟(ECMM)联合欧洲呼吸学会(ERS)联合制定。威廉亚洲博彩公司 建议内容涉及诊断程序，胸部影像学检查，支气管肺泡灌洗和活组织检查，其他位置影像学检查，显微镜下检查以及抗真菌药敏测试等。 </P> <P> </P>拓展威廉亚洲博彩公司 ：<strong>与<font color=red>霉菌</font>相关威廉亚洲博彩公司 ：</strong><br><ul><li><a href="//www.nyrain.com/guideline/show_article.do?id=9f4aa1c00122e695" title="2016IDSA：曲霉菌感染临床实践威廉亚洲博彩公司 " target=_blank>2016IDSA：曲霉菌感染临床实践威廉亚洲博彩公司 </a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=3a3661c0010a2254" title="2013 ESCMID/ECMM联合临床威廉亚洲博彩公司 ：毛霉菌病的诊断和管理" target=_blank>2013 ESCMID/ECMM联合临床威廉亚洲博彩公司 ：毛霉菌病的诊断和管理</a></li> 更多信息请点击：<a href="//www.nyrain.com/guideline/list.do?q=%E9%9C%89%E8%8F%8C" target=_blank>有关霉菌更多威廉亚洲博彩公司 </a></ul>, tagList=[TagDto(tagId=70530, tagName=:), TagDto(tagId=71969, tagName=曲霉菌病)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=威廉亚洲博彩公司 , guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10928, appHits=616, showAppHits=6, pcHits=6984, showPcHits=5200, likes=117, shares=28, comments=12, approvalStatus=1, publishedTime=Tue Mar 20 21:14:49 CST 2018, publishedTimeString=2018-03-12, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Mar 20 21:14:49 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 10:21:23 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 ESCMID/ECMM/ERS威廉亚洲博彩公司 ：曲霉菌病的诊断和管理)])
2017 ESCMID/ECMM/ERS威廉亚洲博彩公司 ：曲霉菌病的诊断和管理
下载请点击：
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1052005, encodeId=ca2f1052005af, content=文章不错 受教了 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Thu Sep 16 15:33:46 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002869, encodeId=776b100286971, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c68d5557440, createdName=ms3000000638617419, createdTime=Mon Jul 26 22:47:48 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969724, encodeId=dc61969e2466, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:39 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969723, encodeId=4cc2969e23b2, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:36 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969722, encodeId=8d09969e2279, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:31 CST 2021, time=2021-05-30, status=1, ipAttribution=)]
    2021-09-16 H8888888

    文章不错 受教了 谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1052005, encodeId=ca2f1052005af, content=文章不错 受教了 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Thu Sep 16 15:33:46 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002869, encodeId=776b100286971, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c68d5557440, createdName=ms3000000638617419, createdTime=Mon Jul 26 22:47:48 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969724, encodeId=dc61969e2466, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:39 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969723, encodeId=4cc2969e23b2, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:36 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969722, encodeId=8d09969e2279, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:31 CST 2021, time=2021-05-30, status=1, ipAttribution=)]
    2021-07-26 ms3000000638617419

    谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1052005, encodeId=ca2f1052005af, content=文章不错 受教了 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Thu Sep 16 15:33:46 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002869, encodeId=776b100286971, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c68d5557440, createdName=ms3000000638617419, createdTime=Mon Jul 26 22:47:48 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969724, encodeId=dc61969e2466, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:39 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969723, encodeId=4cc2969e23b2, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:36 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969722, encodeId=8d09969e2279, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:31 CST 2021, time=2021-05-30, status=1, ipAttribution=)]
    2021-05-30 ms3000001354807136

    可以

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1052005, encodeId=ca2f1052005af, content=文章不错 受教了 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Thu Sep 16 15:33:46 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002869, encodeId=776b100286971, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c68d5557440, createdName=ms3000000638617419, createdTime=Mon Jul 26 22:47:48 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969724, encodeId=dc61969e2466, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:39 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969723, encodeId=4cc2969e23b2, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:36 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969722, encodeId=8d09969e2279, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:31 CST 2021, time=2021-05-30, status=1, ipAttribution=)]
    2021-05-30 ms3000001354807136

    可以

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1052005, encodeId=ca2f1052005af, content=文章不错 受教了 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Thu Sep 16 15:33:46 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002869, encodeId=776b100286971, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c68d5557440, createdName=ms3000000638617419, createdTime=Mon Jul 26 22:47:48 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969724, encodeId=dc61969e2466, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:39 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969723, encodeId=4cc2969e23b2, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:36 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969722, encodeId=8d09969e2279, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210530/c2593ea8bbed438ea1f95cbdf556c768/2fc9aa157cab40fe91945be182d37ff3.jpg, createdBy=e69f5417776, createdName=ms3000001354807136, createdTime=Sun May 30 23:35:31 CST 2021, time=2021-05-30, status=1, ipAttribution=)]
    2021-05-30 ms3000001354807136

    加油

    0

以上为热门评论，williamhill asia 医学App还有更多内容

相关威廉亚洲博彩公司

我国青光眼临床诊断和治疗描述性术语专家建议（2018年）

中华医学会眼科学分会青光眼学组 · 2018-03-10

醋酸钠林格液围手术期临床应用专家共识

中国临床麻醉/疼痛相关专家组（统称） · 2018-02-01

加拿大妇产科医师学会《妊娠期单纯疱疹病毒的管理威廉亚洲博彩公司 》2017版解读

暂未更新 · 2017-12-15

2017 UK专家共识建议：阿柏西普治疗新生血管性年龄相关性黄斑变性

国外眼科专家协作组（统称） · 2017-11-06

2017 国际共识声明：脊髓麻醉下剖宫产手术期间应用血管升压类药物治疗低血压

国外麻醉相关专家组（统称） · 2017-11-01